They are not direct competitors. CYC's biggest market is PE, and 4DX is not in that space......yet. 4DX claim they could have tech to look at PE, but its many years off before the comparative studies are done. These head-to-head clinical trials take time and are costly.
Interestingly, none of the 4DX presentations mention CT Spect with Technegas!
Ann: Cyclopharm Confirms USFDA Scheduled Inspection Date, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.005(0.46%) |
Mkt cap ! $119.4M | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.09 | $1.02 | $9.779K | 9.078K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3106 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 12250 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| CYC (ASX) Chart |